Myrtenyl acetate is a pinane-derived monoterpene ester most relevant in the archive as a chemotype-shaping constituent of some myrtle oils and a recurrent minor constituent in other aromatic materials. The strongest live evidence supports identity, myrtle-occurrence patterns, and fragrance/flavor safety review rather than standalone pharmacology. AromaForge should describe myrtenyl acetate primarily as an aroma-marker ester with solid occurrence data and comparatively limited constituent-specific biological literature.
Chemical identity and composition
PubChem identifies myrtenyl acetate as a bicyclic monoterpene ester with formula C12H18O2. It is the acetylated ester of the myrtenol skeleton and appears in the same EFSA safety subgroup as myrtenol and related pinene-derived flavoring substances.
Aroma and practical use
- Use the recorded fresh, green, piney, herbal, herbaceous descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2021 Moroccan myrtle survey differentiated 33 oils partly by their myrtenyl acetate content and identified distinct 1,8-cineole/myrtenyl acetate and myrtenyl acetate-dominant subgroups.
A 2021 Moroccan myrtle survey differentiated 33 oils partly by their myrtenyl acetate content and identified distinct 1,8-cineole/myrtenyl acetate and myrtenyl acetate-dominant subgroups.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
A 2009 Portuguese myrtle study reported myrtenyl acetate at 6.6-24.8% across berries, branches, and leaves and identified it as one of the oil's major components.
A 2009 Portuguese myrtle study reported myrtenyl acetate at 6.6-24.8% across berries, branches, and leaves and identified it as one of the oil's major components.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
A 2014 Myrtus communis essential-oil paper reported myrtenyl acetate at 20.75% in the tested oil, placing it among the principal quantified constituents alongside 1,8-cineole and alpha-pinene.
A 2014 Myrtus communis essential-oil paper reported myrtenyl acetate at 20.75% in the tested oil, placing it among the principal quantified constituents alongside 1,8-cineole and alpha-pinene.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
A 2022 RIFM fragrance ingredient safety assessment was published specifically for myrtenyl acetate, providing a modern fragrance-use safety review entry for the isolated constituent.
A 2022 RIFM fragrance ingredient safety assessment was published specifically for myrtenyl acetate, providing a modern fragrance-use safety review entry for the isolated constituent.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedEFSA's FGE.208 revision trail and the later RIFM assessment together support that myrtenyl acetate has been specifically reviewed in flavoring and fragrance safety contexts.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
No strong isolated myrtenyl acetate human efficacy literature was verified in this pass, and constituent-level safety framing is more robust than pharmacology framing.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
likely esterase hydrolysis to myrtenol and acetic acid
This is a chemistry-based inference for a simple monoterpene acetate ester rather than a direct mechanistic study on myrtenyl acetate.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- No convincing isolated myrtenyl acetate pharmacology literature was verified beyond broader oil studies and safety reviews.
- A constituent-specific dermal maximum or irritation threshold for myrtenyl acetate was not verified in the reviewed public sources.
- The hydrolysis mechanism note is an inference from ester chemistry, not a direct constituent study.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.